You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Favic is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. Greatest benefit occurs if the drug is started within 48 hours. Efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. Herpes zoster infection is generally a milder condition in younger patients. Favic is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older. Favic is also indicated for suppression of recurrent genital herpes. Favic is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients. Favic is also indicated in immunocompromised patients for: - Treatment of uncomplicated herpes zoster. - Treatment of recurrent herpes simplex. - Suppression of recurrent herpes simplex.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on May, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Favic is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. Greatest benefit occurs if the drug is started within 48 hours. Efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. Herpes zoster infection is generally a milder condition in younger patients. Favic is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older. Favic is also indicated for suppression of recurrent genital herpes. Favic is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients. Favic is also indicated in immunocompromised patients for: - Treatment of uncomplicated herpes zoster. - Treatment of recurrent herpes simplex. - Suppression of recurrent herpes simplex.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on May, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Favic is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. Greatest benefit occurs if the drug is started within 48 hours. Efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. Herpes zoster infection is generally a milder condition in younger patients. Favic is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older. Favic is also indicated for suppression of recurrent genital herpes. Favic is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients. Favic is also indicated in immunocompromised patients for: - Treatment of uncomplicated herpes zoster. - Treatment of recurrent herpes simplex. - Suppression of recurrent herpes simplex.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on May, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Favic is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. Greatest benefit occurs if the drug is started within 48 hours. Efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. Herpes zoster infection is generally a milder condition in younger patients. Favic is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older. Favic is also indicated for suppression of recurrent genital herpes. Favic is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients. Favic is also indicated in immunocompromised patients for: - Treatment of uncomplicated herpes zoster. - Treatment of recurrent herpes simplex. - Suppression of recurrent herpes simplex.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on May, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Favic is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. Greatest benefit occurs if the drug is started within 48 hours. Efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. Herpes zoster infection is generally a milder condition in younger patients. Favic is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older. Favic is also indicated for suppression of recurrent genital herpes. Favic is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients. Favic is also indicated in immunocompromised patients for: - Treatment of uncomplicated herpes zoster. - Treatment of recurrent herpes simplex. - Suppression of recurrent herpes simplex.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Favic is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. Greatest benefit occurs if the drug is started within 48 hours. Efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. Herpes zoster infection is generally a milder condition in younger patients. Favic is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older. Favic is also indicated for suppression of recurrent genital herpes. Favic is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients. Favic is also indicated in immunocompromised patients for: - Treatment of uncomplicated herpes zoster. - Treatment of recurrent herpes simplex. - Suppression of recurrent herpes simplex.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on May, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Favic is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. Greatest benefit occurs if the drug is started within 48 hours. Efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. Herpes zoster infection is generally a milder condition in younger patients. Favic is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older. Favic is also indicated for suppression of recurrent genital herpes. Favic is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients. Favic is also indicated in immunocompromised patients for: - Treatment of uncomplicated herpes zoster. - Treatment of recurrent herpes simplex. - Suppression of recurrent herpes simplex.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on May, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
